{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:20:54Z","timestamp":1791170454054,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-04811-w","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T04:03:03Z","timestamp":1677643383000},"page":"1965-1976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical manifestations of Lyme neuroborreliosis in children: a review"],"prefix":"10.1007","volume":"182","author":[{"given":"R. A.","family":"Bruinsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. P.","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. H.","family":"Skogman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Boele","family":"van Hensbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"4811_CR1","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","volume":"362","author":"G Stanek","year":"2003","unstructured":"Stanek G, Strle F (2003) Lyme borreliosis. Lancet 362:1639\u20131647. https:\/\/doi.org\/10.1016\/S0140-6736(03)14798-8","journal-title":"Lancet"},{"key":"4811_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379:461\u2013473. https:\/\/doi.org\/10.1016\/S0140-6736(11)60103-7","journal-title":"Lancet"},{"key":"4811_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","volume":"27","author":"BH Skogman","year":"2008","unstructured":"Skogman BH, Croner S, Nordwall M et al (2008) Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 27:1089\u20131094. https:\/\/doi.org\/10.1097\/INF.0b013e31817fd423","journal-title":"Pediatr Infect Dis J"},{"key":"4811_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/313982","volume":"31","author":"ED Shapiro","year":"2000","unstructured":"Shapiro ED, Gerber MA (2000) Lyme disease. Clin Infect Dis 31:533\u2013542. https:\/\/doi.org\/10.1086\/313982","journal-title":"Clin Infect Dis"},{"key":"4811_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJM199511163332004","volume":"333","author":"J Berglund","year":"1995","unstructured":"Berglund J, Eitrem R, Ornstein K et al (1995) An Epidemiologic Study of Lyme Disease in southern Sweden. N Engl J Med 333:1319\u20131324. https:\/\/doi.org\/10.1056\/NEJM199511163332004","journal-title":"N Engl J Med"},{"key":"4811_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/INF.0000000000002493","volume":"39","author":"K Krawczuk","year":"2020","unstructured":"Krawczuk K, Czupryna P, Pancewicz S et al (2020) Comparison of Neuroborreliosis between children and adults. Pediatr Infect Dis J 39:7\u201311. https:\/\/doi.org\/10.1097\/INF.0000000000002493","journal-title":"Pediatr Infect Dis J"},{"key":"4811_CR7","doi-asserted-by":"crossref","unstructured":"Kozak S, Kamini\u00f3w K, Kozak K, Paprocka J (2021) Lyme neuroborreliosis in children. Brain Sci","DOI":"10.3390\/brainsci11060758"},{"key":"4811_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"\u00c5 Mygland","year":"2010","unstructured":"Mygland \u00c5, Lj\u00f8stad U, Fingerle V et al (2010) EFNS guidelines on the diagnosis and management of European lyme neuroborreliosis. Eur J Neurol 17:8\u201316. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02862.x","journal-title":"Eur J Neurol"},{"key":"4811_CR9","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1097\/INF.0000000000002415","volume":"38","author":"M Ro\u017ei\u010d","year":"2019","unstructured":"Ro\u017ei\u010d M, Lah LL, Ru\u017ei\u0107-Sablji\u0107 E et al (2019) Lyme neuroborreliosis in children. Pediatr Infect Dis J 38:e279\u2013e284. https:\/\/doi.org\/10.1097\/INF.0000000000002415","journal-title":"Pediatr Infect Dis J"},{"key":"4811_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/INF.0000000000001653","volume":"36","author":"L S\u00f6dermark","year":"2017","unstructured":"S\u00f6dermark L, Sigurdsson V, N\u00e4s W et al (2017) Neuroborreliosis in Swedish children: a population-based study on incidence and clinical characteristics. Pediatr Infect Dis J 36:1052\u20131056. https:\/\/doi.org\/10.1097\/INF.0000000000001653","journal-title":"Pediatr Infect Dis J"},{"key":"4811_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","volume":"14","author":"U Lj\u00f8stad","year":"2007","unstructured":"Lj\u00f8stad U, Skarpaas T, Mygland \u00c5 (2007) Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14:873\u2013876. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01799.x","journal-title":"Eur J Neurol"},{"key":"4811_CR12","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269672.17807.e0","author":"F Blanc","year":"2007","unstructured":"Blanc F, Jaulhac B, Fleury M et al (2007) Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000269672.17807.e0","journal-title":"Neurology"},{"key":"4811_CR13","first-page":"171","volume":"24","author":"RB Dessau","year":"2017","unstructured":"Dessau RB, van Dam AP, Fingerle V et al (2017) To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect 24:171\u2013174","journal-title":"Clin Microbiol Infect"},{"key":"4811_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04129-7","author":"BH Skogman","year":"2021","unstructured":"Skogman BH, Wilhelmsson P, Atallah S et al (2021) Lyme neuroborreliosis in Swedish children\u2014PCR as a complementary diagnostic method for detection of Borrelia burgdorferi sensu lato in cerebrospinal fluid. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/s10096-020-04129-7","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4811_CR15","doi-asserted-by":"crossref","unstructured":"Ru\u017ei\u0107-Sablji\u0107 E, Cerar T (2017) Progress in the molecular diagnosis of Lyme disease. Expert Rev Mol Diagn","DOI":"10.1080\/14737159.2016.1246959"},{"key":"4811_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01868-17","author":"B Barstad","year":"2018","unstructured":"Barstad B, Quarsten H, Tveitnes D et al (2018) Direct molecular detection and genotyping of borrelia burgdorferi sensu lato in cerebrospinal fluid of children with lyme neuroborreliosis. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.01868-17","journal-title":"J Clin Microbiol"},{"key":"4811_CR17","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/diagnostics11112088","volume":"11","author":"M Lager","year":"2021","unstructured":"Lager M, Wilhelmsson P, Matussek A et al (2021) Molecular detection of borrelia bacteria in cerebrospinal fluid-optimisation of pre-analytical sample handling for increased analytical sensitivity. Diagnostics 11:2088. https:\/\/doi.org\/10.3390\/diagnostics11112088","journal-title":"Diagnostics"},{"key":"4811_CR18","doi-asserted-by":"crossref","unstructured":"Rupprecht TA, Manz KM, Fingerle V et al (2018) Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis. Clin Microbiol Infect","DOI":"10.1016\/j.cmi.2018.04.007"},{"key":"4811_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.11.005","author":"I Tjernberg","year":"2011","unstructured":"Tjernberg I, Henningsson AJ, Eliasson I et al (2011) Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect. https:\/\/doi.org\/10.1016\/j.jinf.2010.11.005","journal-title":"J Infect"},{"key":"4811_CR20","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s10096-018-3334-3","volume":"37","author":"AJ Henningsson","year":"2018","unstructured":"Henningsson AJ, Lager M, Br\u00e4nnstr\u00f6m R et al (2018) The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis. Eur J Clin Microbiol Infect Dis 37:1983\u20131991. https:\/\/doi.org\/10.1007\/s10096-018-3334-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4811_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-103","author":"J Hyt\u00f6nen","year":"2014","unstructured":"Hyt\u00f6nen J, Kortela E, Waris M et al (2014) CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. J Neuroinflammation. https:\/\/doi.org\/10.1186\/1742-2094-11-103","journal-title":"J Neuroinflammation"},{"key":"4811_CR22","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2016.0101","author":"J Yang","year":"2017","unstructured":"Yang J, Han X, Liu A et al (2017) Chemokine CXC ligand 13 in cerebrospinal fluid can be used as an early diagnostic biomarker for Lyme neuroborreliosis: a meta-analysis. J Interf Cytokine Res. https:\/\/doi.org\/10.1089\/jir.2016.0101","journal-title":"J Interf Cytokine Res"},{"key":"4811_CR23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10096-020-03861-4","volume":"39","author":"FC Knudtzen","year":"2020","unstructured":"Knudtzen FC, Nilsson AC, Hovius JW, Skarphedinsson S (2020) The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study. Eur J Clin Microbiol Infect Dis 39:1461\u20131470. https:\/\/doi.org\/10.1007\/s10096-020-03861-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4811_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2019.1671988","author":"B Barstad","year":"2019","unstructured":"Barstad B, Tveitnes D, Dalen I et al (2019) The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables. Infect Dis (Auckl). https:\/\/doi.org\/10.1080\/23744235.2019.1671988","journal-title":"Infect Dis (Auckl)"},{"key":"4811_CR25","doi-asserted-by":"publisher","unstructured":"Skogman BH, Lager M, Brudin L et al (2020) Cytokines and chemokines in cerebrospinal fluid in relation to diagnosis, clinical presentation and recovery in children being evaluated for Lyme neuroborreliosis. Ticks Tick Borne Dis 11:101390. https:\/\/doi.org\/10.1016\/j.ttbdis.2020.101390","DOI":"10.1016\/j.ttbdis.2020.101390"},{"key":"4811_CR26","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1542\/peds.2008-1273","volume":"122","author":"LE Nigrovic","year":"2008","unstructured":"Nigrovic LE, Thompson AD, Fine AM, Kimia A (2008) Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area. Pediatrics 122:e1080\u2013e1085. https:\/\/doi.org\/10.1542\/peds.2008-1273","journal-title":"Pediatrics"},{"key":"4811_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/archdischild-2011-300526","volume":"97","author":"D Tveitnes","year":"2012","unstructured":"Tveitnes D, Nat\u00e5s OB, Skadberg \u00d8, \u00d8ymar K (2012) Lyme meningitis, the major cause of childhood meningitis in an endemic area: a population based study. Arch Dis Child 97:215\u2013220. https:\/\/doi.org\/10.1136\/archdischild-2011-300526","journal-title":"Arch Dis Child"},{"key":"4811_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318191f035","author":"D Tuerlinckx","year":"2009","unstructured":"Tuerlinckx D, Bodart E, Jamart J, Glupczynski Y (2009) Prediction of lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis: a European study. Pediatr Infect Dis J. https:\/\/doi.org\/10.1097\/INF.0b013e318191f035","journal-title":"Pediatr Infect Dis J"},{"key":"4811_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-015-0537-y","author":"BH Skogman","year":"2015","unstructured":"Skogman BH, Sj\u00f6wall J, Lindgren PE (2015) The NeBoP score - a clinical prediction test for evaluation of children with Lyme Neuroborreliosis in Europe. BMC Pediatr. https:\/\/doi.org\/10.1186\/s12887-015-0537-y","journal-title":"BMC Pediatr"},{"key":"4811_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12887-018-1163-2","volume":"18","author":"K Backman","year":"2018","unstructured":"Backman K, Skogman BH (2018) Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome \u2013 a prospective cohort study. BMC Pediatr 18:189. https:\/\/doi.org\/10.1186\/s12887-018-1163-2","journal-title":"BMC Pediatr"},{"key":"4811_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1542\/peds.2011-3719","volume":"130","author":"BH Skogman","year":"2012","unstructured":"Skogman BH, Glim\u00e5ker K, Nordwall M et al (2012) Long-term clinical outcome after Lyme neuroborreliosis in childhood. Pediatrics 130:262\u2013269. https:\/\/doi.org\/10.1542\/peds.2011-3719","journal-title":"Pediatrics"},{"key":"4811_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00431-011-1542-2","volume":"171","author":"M Sundin","year":"2012","unstructured":"Sundin M, Hansson MEA, Engman M-L et al (2012) Pediatric tick-borne infections of the central nervous system in an endemic region of Sweden: a prospective evaluation of clinical manifestations. Eur J Pediatr 171:347\u2013352. https:\/\/doi.org\/10.1007\/s00431-011-1542-2","journal-title":"Eur J Pediatr"},{"key":"4811_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1651-2227.1993.tb18082.x","volume":"82","author":"H-J Christen","year":"1993","unstructured":"Christen H-J, Hanefeld F, Eiffert H, Thomssen R (1993) Epidemiology and Clinical manifestations of Lyme borreliosis in childhood. Acta Paediatr 82:1\u201376. https:\/\/doi.org\/10.1111\/j.1651-2227.1993.tb18082.x","journal-title":"Acta Paediatr"},{"key":"4811_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/femsre\/fux047","volume":"42","author":"G Stanek","year":"2018","unstructured":"Stanek G, Strle F (2018) Lyme borreliosis\u2013from tick bite to diagnosis and treatment. FEMS Microbiol Rev 42:233\u2013258. https:\/\/doi.org\/10.1093\/femsre\/fux047","journal-title":"FEMS Microbiol Rev"},{"key":"4811_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/cid\/cix568","volume":"65","author":"FC Knudtzen","year":"2017","unstructured":"Knudtzen FC, Andersen NS, Jensen TG, Skarph\u00e9dinsson S (2017) Characteristics and clinical outcome of Lyme neuroborreliosis in a high endemic area, 1995\u20132014: a retrospective cohort study in Denmark. Clin Infect Dis 65:1489\u20131495. https:\/\/doi.org\/10.1093\/cid\/cix568","journal-title":"Clin Infect Dis"},{"key":"4811_CR36","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1469-0691.2009.03059.x","volume":"16","author":"AJ Henningsson","year":"2010","unstructured":"Henningsson AJ, Malmvall B-E, Ernerudh J et al (2010) Neuroborreliosis\u2014an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 16:1245\u20131251. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.03059.x","journal-title":"Clin Microbiol Infect"},{"key":"4811_CR37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/adc.2009.176529","volume":"95","author":"DM Broekhuijsen-van Henten","year":"2010","unstructured":"Broekhuijsen-van Henten DM, Braun KPJ, Wolfs TFW (2010) Clinical presentation of childhood neuroborreliosis; neurological examination may be normal. Arch Dis Child 95:910\u2013914. https:\/\/doi.org\/10.1136\/adc.2009.176529","journal-title":"Arch Dis Child"},{"key":"4811_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/00365540802593453","volume":"41","author":"K \u00d8ymar","year":"2009","unstructured":"\u00d8ymar K, Tveitnes D (2009) Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe. Scand J Infect Dis 41:88\u201394. https:\/\/doi.org\/10.1080\/00365540802593453","journal-title":"Scand J Infect Dis"},{"key":"4811_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/00365540601105764","volume":"39","author":"D Tveitnes","year":"2007","unstructured":"Tveitnes D, \u00d8ymar K, Nat\u00e5s O (2007) Acute facial nerve palsy in children: how often is it Lyme borreliosis? Scand J Infect Dis 39:425\u2013431. https:\/\/doi.org\/10.1080\/00365540601105764","journal-title":"Scand J Infect Dis"},{"key":"4811_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0950268819000438","volume":"147","author":"SM Bierman","year":"2019","unstructured":"Bierman SM, van Kooten B, Vermeeren YM et al (2019) Incidence and characteristics of Lyme neuroborreliosis in adult patients with facial palsy in an endemic area in the Netherlands. Epidemiol Infect 147:1\u20136. https:\/\/doi.org\/10.1017\/S0950268819000438","journal-title":"Epidemiol Infect"},{"key":"4811_CR41","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1136\/bjophthalmol-2015-306855","volume":"99","author":"MH Correll","year":"2015","unstructured":"Correll MH, Datta N, Arvidsson HSS et al (2015) Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children. Br J Ophthalmol 99:1401\u20131404. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306855","journal-title":"Br J Ophthalmol"},{"key":"4811_CR42","unstructured":"Celik T, Celik U, K\u00f6m\u00fcr M et al (2016) Pediatric Lyme neuroborreliosis: different clinical presentations of the same agent; Single center experience. Neuro Endocrinol Lett"},{"key":"4811_CR43","doi-asserted-by":"crossref","unstructured":"Koster MP, Garro A (2018) Unraveling diagnostic uncertainty surrounding Lyme Disease in children with neuropsychiatric illness. Child Adolesc Psychiatr Clin N Am","DOI":"10.1016\/j.chc.2017.08.010"},{"key":"4811_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejpn.2017.10.010","volume":"22","author":"O Monteventi","year":"2018","unstructured":"Monteventi O, Steinlin M, Reg\u00e9nyi M et al (2018) Pediatric stroke related to Lyme neuroborreliosis: data from the Swiss NeuroPaediatric Stroke Registry and literature review. Eur J Paediatr Neurol 22:113\u2013121. https:\/\/doi.org\/10.1016\/j.ejpn.2017.10.010","journal-title":"Eur J Paediatr Neurol"},{"key":"4811_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-8007-x","author":"S Ramgopal","year":"2016","unstructured":"Ramgopal S, Obeid R, Zuccoli G et al (2016) Lyme disease-related intracranial hypertension in children: clinical and imaging findings. J Neurol. https:\/\/doi.org\/10.1007\/s00415-015-8007-x","journal-title":"J Neurol"},{"key":"4811_CR46","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010088","author":"RR Seese","year":"2020","unstructured":"Seese RR, Guillen D, Gaesser JM, Abdel-Hamid HZ (2020) Clinical reasoning: a 14-year-old boy with acute weakness, paresthesias, and headache. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000010088","journal-title":"Neurology"},{"key":"4811_CR47","unstructured":"Dutch Quality Institute for Health Care (CBO) (2013) Dutch national Guideline for Lyme disease"},{"key":"4811_CR48","doi-asserted-by":"publisher","unstructured":"Rauer S, Kastenbauer S, Hofmann H et al (2020) Guidelines for diagnosis and treatment in neurology \u2013 lyme neuroborreliosis. GMS Ger Med Sci 18. https:\/\/doi.org\/10.3205\/000279","DOI":"10.3205\/000279"},{"key":"4811_CR49","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3399\/bjgp18X699713","volume":"68","author":"C Rayment","year":"2018","unstructured":"Rayment C, O\u2019Flynn N (2018) Diagnosis and management of patients with Lyme disease: NICE guideline. Br J Gen Pract 68:546\u2013547. https:\/\/doi.org\/10.3399\/bjgp18X699713","journal-title":"Br J Gen Pract"},{"key":"4811_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12887-022-03335-w","volume":"22","author":"S Arnason","year":"2022","unstructured":"Arnason S, Skogman BH (2022) Effectiveness of antibiotic treatment in children with Lyme neuroborreliosis - a retrospective study. BMC Pediatr 22:332. https:\/\/doi.org\/10.1186\/s12887-022-03335-w","journal-title":"BMC Pediatr"},{"key":"4811_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1215","author":"PM Lantos","year":"2021","unstructured":"Lantos PM, Rumbaugh J, Bockenstedt LK et al (2021) Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1215","journal-title":"Clin Infect Dis"},{"key":"4811_CR52","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (2021) Red book: 2021\u20132024 Report of Committee on Infectious Diseaes of the American Academy of Pediatrics, 32nd ed","DOI":"10.1542\/9781610025225"},{"key":"4811_CR53","doi-asserted-by":"crossref","unstructured":"Cross R, Ling C, Day NPJ et al (2016) Revisiting doxycycline in pregnancy and early childhood - time to rebuild its reputation? Expert Opin Drug Saf","DOI":"10.1517\/14740338.2016.1133584"},{"key":"4811_CR54","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1349724","author":"S Zotter","year":"2013","unstructured":"Zotter S, Koch J, Schlachter K et al (2013) Neuropsychological profile of children after an episode of neuroborreliosis. Neuropediatrics. https:\/\/doi.org\/10.1055\/s-0033-1349724","journal-title":"Neuropediatrics"},{"key":"4811_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110080421","author":"J Berglund","year":"2002","unstructured":"Berglund J, Stjernberg L, Ornstein K et al (2002) 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis. https:\/\/doi.org\/10.1080\/00365540110080421","journal-title":"Scand J Infect Dis"},{"key":"4811_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","volume":"263","author":"R Dersch","year":"2016","unstructured":"Dersch R, Sommer H, Rauer S, Meerpohl JJ (2016) Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. J Neurol 263:17\u201324. https:\/\/doi.org\/10.1007\/s00415-015-7923-0","journal-title":"J Neurol"},{"key":"4811_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM200107123450202","volume":"345","author":"MS Klempner","year":"2001","unstructured":"Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85\u201392. https:\/\/doi.org\/10.1056\/NEJM200107123450202","journal-title":"N Engl J Med"},{"key":"4811_CR58","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000071227.23769.9E","author":"LB Krupp","year":"2003","unstructured":"Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. https:\/\/doi.org\/10.1212\/01.WNL.0000071227.23769.9E","journal-title":"Neurology"},{"key":"4811_CR59","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","volume":"70","author":"BA Fallon","year":"2008","unstructured":"Fallon BA, Keilp JG, Corbera KM et al (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70:992\u20131003. https:\/\/doi.org\/10.1212\/01.WNL.0000284604.61160.2d","journal-title":"Neurology"},{"key":"4811_CR60","first-page":"489","volume":"99","author":"D Cameron","year":"2008","unstructured":"Cameron D (2008) Severity of lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med 99:489\u2013496","journal-title":"Minerva Med"},{"key":"4811_CR61","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","volume":"374","author":"A Berende","year":"2016","unstructured":"Berende A, ter Hofstede HJM, Vos FJ et al (2016) Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med 374:1209\u20131220. https:\/\/doi.org\/10.1056\/NEJMoa1505425","journal-title":"N Engl J Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-04811-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:36:37Z","timestamp":1683786997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-04811-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["4811"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-04811-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}